Furthermore, 6-methoxymellein inhibits the proliferation and migration of BC cells, reduces mammosphere growth, and decease CD44+/CD24− population as well as, diminish the expression of c-Myc, Sox-2 and Oct4. Here, SOX2 is linked to breast cancer.